Skip Content
You are currently on the new version of our website. Access the old version .
  • Indexed in
    Scopus
  • 24 days
    Time to First Decision

Onco, Volume 2, Issue 1

2022 March - 4 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

  • Review
  • Open Access
7 Citations
6,643 Views
20 Pages

25 February 2022

The high incidence and modest therapeutic outcomes of lung cancer have prompted the identification of cell molecular targets/biomarkers within the complex networks of interactions involved in cell malignancy. Most of the EMT-related regulatory mediat...

  • Article
  • Open Access
8 Citations
5,422 Views
15 Pages

Optimizing the Pharmacological and Optical Dosimetry for Photodynamic Therapy with Methylene Blue and Nanoliposomal Benzoporphyrin on Pancreatic Cancer Spheroids

  • Tristan Le Clainche,
  • Nazareth Milagros Carigga Gutierrez,
  • Núria Pujol-Solé,
  • Jean-Luc Coll and
  • Mans Broekgaarden

7 January 2022

Photodynamic therapy (PDT) is a cancer treatment that relies on the remote-controlled activation of photocatalytic dyes (photosensitizers) in cancer tissues. To effectively treat cancer, a variety of pharmacological and optical parameters require opt...

  • Article
  • Open Access
3 Citations
3,698 Views
18 Pages

30 December 2021

The use of core needle biopsy (CNB) as a means to verify malignancy preoperatively is a paradigm in current breast cancer care, and the risk of enhancing tumor development by this procedure has been considered insignificant. Experimental work in mice...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Onco - ISSN 2673-7523